 |
Post-tests not yet ready |

|
Inherited Defects in Urinary Concentration
Daniel Bichet, MD |

|
Calciphylaxis
Anthony Bleyer, MD |
CME accreditation good until May 1,
2006 |

1.5 |
Non-Standard Therapy in Membranous Nephropathy
Giuseppe Remuzzi, MD |
Acute Renal Failure and Chronic Renal Failure
after Orthotopic Liver Transplantation Gabriel
Contreras, MD, MPH |

2.0 |
Sexual Dysfunction in Patients with Chronic Kidney
Disease Biff L. Palmer, MD |
Sleep Apnea: ESRD vs. the General Population
Robert L. Benz, MD |
Vexing Problems in the dialysis unit:
Heparin-induced Thrombocytopenia Eugene C.
Kovalik, MD |

1.5 |
The Metabolic Syndrome and Kidney Disease: An
Important Complication of Systemic Vascular Disease
Katherine R. Tuttle, MD |
Coronary Artery Catheterization in Chronic Kidney
Disease: Indications and Management with Stent or Bypass
Connie L. Manske, MD |

2.0 |
Indications for Immunosuppression in Membranous
Nephropathy Daniel C. Cattran, MD |
ANCA-associated RPGN: Role of Plasmapheresis
Charles D. Pusey, MD |
Therapy of ANCA-Associated Vasculitis and the EUVAS
Trials David Jayne, MD |

|
Management of Fistula Failures
Gerald A. Beathard, MD |

1.5 |
Primary Prevention of Dye-Induced Acute Renal
Failure Samuel N. Heyman, MD |
When and How to Use the Selective Aldosterone
Receptor Antagonists to Optimize Cardiorenal Event Reduction
George Bakris, MD |

1.0 |
New Insights in the Pathogenesis of Uric Acid
Nephrolithiasis Khashayar Sakhaee, MD |

1.5 |
Official Symposium: Cardiovascular Disease in CKD:
Strategies for Reducing Risk George Aronoff, MD;
Phyllis August, MD; Jonathan Himmelfarb, MD; David Van Wyck,
MD; (ASN Renal Week Official Symposium, St. Louis, MO, 2004)
|

1.5 |
Official Symposium: Infections and Renal Complications
of Immunosuppression: An Update David Roth, MD;
Connie L. Davis, MD; Daniel C. Brennan, MD. (ASN Renal Week
Official Symposium, St. Louis, MO, 2004) |

3.5 |
Chronic allograft nephropathy and recurrent
disease Brian J. Nankivell, MD |
Donor - Recipient Evaluation Connie
Davis, MD |
B Cell and the Humoral Alloimmune Response
Mark D. Denton, MD, PhD |
Immunosuppression: Induction and Maintenance
Flavio Vincenti, MD |

2.0 |
Official Symposium: Emerging Data on Iron Management:
Clinical Implications Daniel Coyne, MD; Bradley A.
Warady, MD, Kamyar Kalantar-Zadeh, MD, PhD, MPH; Allen R.
Nissenson, MD. (Moderator: Allen R. Nissenson, MD) ASN Renal
Week Official Symposium, St. Louis, MO, 2004) |

2.0 |
Official Symposium: CKD and CHF: the Silent Threat.
Donald Silverberg, MD, Ajay K. Singh, MB, MRCP,
and Anju Nohria, MD; (Moderator: Robert Provenzano, MD.) ASN
Renal Week Official Symposium, St. Louis, MO, 2004)
|

1.5 |
Official Symposium: Meeting the K/DOQI Mineral and
Bone Guidelines in CKD (Stages 3 and 4): The Essential Role of
Vitamin D (Glenville Jones, PhD, Jill S. Lindberg,
MD; (Moderator: Tilman Drueke, MD.) ASN Renal Week Official
Symposium, St. Louis, MO, 2004) |

1.0 |
Fetal Kidney Cells, Identification And Roles As
Future Therapeutic Agents Stanton Gerson,
MD |

2.0 |
Official Symposium: Patients with CKD: Preventing the
Complications of Mineral and Metal Accumulation in a Closed
System Paolo Raggi, MD, John Rumberger, PhD, MD,
and Sharon M. Moe, MD. Moderators: Sharon M. Moe, MD and
Isidro B. Salusky, MD. |

1.0 |
Renin-Angiotensin System Actions and
Interactions in CKD Sharon Anderson,
MD |

1.5 |
Official Symposium: AA Amyloidosis: Diagnosis and
Management. Maria Picken, MD, PhD and Joseph
Mikhael, MD, MEd |

1.0 |
Advances in Treatment of FSGS
Frederick. J. Kaskel, MD |

1.0 |
Official Symposium: Evolving Strategies for
Renoprotection: From ACEI to Enzyme Replacement Therapy (ERT).
Fabry's Disease. The Nephrologist's Perspective.
David Warnock, MD and Barry Brenner, MD
(discussant) |

1.0 |
Basic Science Conference. Aldosterone: Its
Receptor, Target Genes, and Actions David Pearce,
MD |

1.0 |
Postgraduate Education Course: Biology of Stent
Stenosis and Potential Therapies Alexander Clowes,
MD |
 |
To
disseminate new knowledge regarding scientific and clinical
discoveries in the field of nephrology |
 |
To
expand the scope of research in nephrology by providing
exciting advances in related disciplines |
 |
To
discuss contemporary standards and new approaches to clinical
care in order to ensure the highest quality of care for
patients with renal disease and related disorders |
 |
To
review, update, and put into perspective the recent advances
in many key areas of general nephrology, dialysis, transplantation,
and hypertension |
|
See Individual Lecture Pages
|
|  |
Each talk, depending
on its length, is accredited
for up to 1.0 CME Category
1 credits by the American
Society of Nephrology.
Sometimes talks are organized
into groups of two or more
and paired with a single CME
post-test, which must be completed
along with an evaluation form
for 1.0 or more CME Category
1 credits. |
| Date of Web Release: See
individual talks
CME Credit Eligible Through: See individual talks
CME Category 1 Credits/Completion Time: See individual
talks
Target Audiences: Nephrology
Board and Recertification candidates practicing nephrologists
and internists.
Method of participation: Listen to the
talk, read the
PubMed abstracts linked to data slides and talk references, take
the post-test,
read the abstracts linked to post-test answer feedback material.
|
Chronic kidney disease affects 30-40 million Americans, of whom several
thousand require renal replacement therapy. These selected lectures
are chosen by the HDCN editor and ASN Postgraduate Medical Director
to reflect those areas of practice of greatest interest to the
clinician, and areas where recent progress has occurred. The
web extension of these ASN lectures will allow nephrologists
and other physicians who were unable to attend the live sessions
to gain similar benefit from these presentations.
ACCREDITATION AND DESIGNATION STATEMENTS: |
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing
medical education for physicians.
The American Society of Nephrology designates this educational
activity for category 1 credit toward the AMA Physician's Recognition
Award. Each physician should claim only those credits that he/she
actually spent in the activity.
The American Medical Association has determined that non-US
licensed physicians who participate in this CME activity are
eligible for AMA PRA category 1 credit.
All lectures selected were from Renal Week 2004, and all were put
together under supervision of the ASN Scientific
Program Committee. Web posting of lectures in the free zone was supported
by grants to the ASN from pharmaceutical companies. See each symposium
page for details of industry sponsorship and support.
FACULTY DISCLOSURE STATEMENTS : |
American Society of Nephrology as well as HDCN have conflict of interest
policies that requires course faculty to disclose any real or
apparent commercial financial affiliations related to the content
of their presentations/materials. It is not assumed that these
financial interests or affiliations will have an adverse impact
on faculty presentations; they are simply noted here to fully
inform participants. Speaker disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE: |
This educational activity may contain discussion of
published and/or
investigational uses of agents that are not indicated by FDA. The
American Society
of Nephrology and HDCN do not
recommend the
use of any agent outside of the labeled indications. Please refer
to the official
prescribing information for each product for discussion of approved
indications,
contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not
meant to serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed
or suggested in this activity should not be used by clinicians
without evaluation of their patient's conditions and possible
contraindications on dangers in use, review of any applicable
manufacturer's product information, and comparison with recommendations
of other authorities.
To complete this educational activity, the user will need Windows or Macintosh operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or
the Real Player from Real Media (www.real.com) is required and either can be downloaded for free
per instructions on the individual lecture pages. Acrobat Reader is required to print the CME
certificate, and this can be download free from www.adobe.com.
For any questions concerning this specific activity please send
an email to
or email@asn-online.org,
or call HDCN at 630-325-3276.
For any general questions concerning ASN CME, please contact the American Society of Nephrology.
| |